PDGFRA and gastrointestinal stromal tumor: In our 80 samples, we obtained a mutation frequency of 87.2%, with 75.7% of the cases harboring KIT mutations and 11.5% showing PDGFRA mutations, which is significantly higher than the 63% recently found in a second Portuguese series of GIST [26] and that of another Iberian Peninsula series [27].